Mucopolysaccharidosis Market Research Report and Forecast 2026–2036
This growth is primarily because developing drugs for rare diseases is often simpler than developing drugs for more common pharmaceutical portfolios. Additionally, pharmaceutical companies are required to conduct large-scale studies for traditional therapies, whereas the testing requirements for therapies targeting